Sunpointe’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.6M Sell
8,301
-618
-7% -$188K 1.02% 29
2026
Q1
$1.91M Buy
8,919
+663
+8% +$148K 0.62% 38
2025
Q4
$1.42M Buy
8,256
+43
+0.5% +$6.69K 0.47% 45
2025
Q3
$1.1M Sell
8,213
-34
-0.4% -$3.6K 0.4% 54
2025
Q2
$805K Sell
8,247
-722
-8% -$57.3K 0.32% 70
2025
Q1
$654K Sell
8,969
-55
-0.6% -$4.33K 0.35% 63
2024
Q4
$654K Sell
9,024
-376
-4% -$28.5K 0.33% 67
2024
Q3
$770K Buy
9,400
+90
+1% +$7.83K 0.63% 37
2024
Q2
$994K Buy
9,310
+160
+2% +$15.3K 0.65% 32
2024
Q1
$891K Buy
9,150
+10
+0.1% +$880 0.99% 24
2023
Q4
$718K Buy
+9,140
New +$623K 0.91% 26

Other funds holding LRCX

Sunpointe's LRCX Position: Q2 2026 in Review

Sunpointe reduced its Lam Research (LRCX) stake by 6.9% in Q2 2026, selling an estimated $188K and leaving 8,301 shares worth $3.6M. The position accounts for 1.02% of the portfolio, ranked #29.

Sunpointe first reported a position in LRCX in Q4 2023 and has held it in 11 quarters since. 3,130 funds tracked by Wall St. Rank hold LRCX as of Q2 2026.

  • Sunpointe held 8,301 shares of Lam Research worth $3.6M as of Q2 2026.
  • Sunpointe sold 618 Lam Research shares in Q2 2026, an estimated $188K.
  • Lam Research made up 1.02% of Sunpointe's portfolio in Q2 2026, its #29 holding.
  • Sunpointe first reported a position in Lam Research in Q4 2023 and has held it in 11 quarters since.
  • 3,130 funds tracked by Wall St. Rank held Lam Research as of Q2 2026.

Based on Sunpointe's 13F filing for Q2 2026, filed 24 Jul 2026.